Insight

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Photo generated from onlinelibrary.wiley.com

Mar 9, 2024, 14:13

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), shared a post on LinkedIn:

“Proud to see this super interesting study published in HemaSphere Journal, the journal of European Hematology Association (EHA):

This work by Pablo Menendez Bujan and co-workers generated a single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples and identify the role of the HIF pathway in drug resistance. They demonstrate that chemical inhibition of HIF cooperates with standard-of-care chemotherapy to impair AML growth and eliminate AML stem cells“.

View the article.
Source: Jan Cools/LinkedIn

AML stem cells chemical inhibition of HIF drug resistance European Hematology Association HemaSphere Journal HIF pathway Jan Cools OncoDaily Pablo Menendez Bujan

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage